Sources: 1BitterDB, 4ClinicalTrials, 7Cochrane Library, 10DGIdb, 14DrugBank, 29HMDB, 33IUPHAR, 35LifeMap Discovery®, 46NDF-RT, 50Novoseek, 56PharmGKB, 68UMLSSee all MalaCards sources |
Drugs for Wiskott-Aldrich Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 266)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Amlodipine | approved | Phase 4 | 496 | 88150-42-9 | 2162 | ()-Amlodipine (RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate -3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl) 3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester 3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate 3-Ethyl-5-methyl ( -)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat 3-Ethyl-5-methyl ( -)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate 3-Ethyl-5-methyl (.+/-.)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate 3-ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate 88150-42-9 88150-47-4 (maleate (1:1)) AC-4535 AC1L1D26 AC1Q32ZS AMLODIPINE BASE AMVAZ Ambap88150-42-9 Amlocard Amlodipine Amlodipine (INN) Amlodipine Benzenesulfonate Amlodipine Besilate Amlodipine Besylate Amlodipine Free Base Amlodipine [INN:BAN] Amlodipine besilate Amlodipine besylate Amlodipine free base Amlodipino Amlodipino [Spanish] Amlodipinum Amlodipinum [Latin] Amlodis Amlopres Amlor | Amvaz BIDD:GT0810 BRD-A22032524-074-02-4 BRD-A22032524-074-03-2 BSPBio_002727 C06825 CHEBI:2668 CHEMBL1491 CID2162 CPD000469198 Coroval D07450 DB00381 HMS2052N03 HMS2089H07 I14-0798 Intervask Istin KBio3_001947 KBioGR_001643 LS-131183 Lipinox Lotrel MLS001401409 MolPort-001-792-963 NCGC00165957-01 NCGC00165957-02 NCGC00165957-03 Norvasc Norvasc (TN) Pelmec R,S)-Amlodipine Racemic Amlodipine SAM001246705 SMR000469198 SPBio_000351 Spectrum2_000486 Spectrum3_001004 Spectrum4_001132 Spectrum5_001550 UK-4834011 UNII-1J444QC288 amlodipine |
| | 2 | | Benazepril | approved, investigational | Phase 4 | 45 | 86541-75-5 | 5362124 | 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid 86541-75-5 AC1NSFPL BIDD:GT0800 BRD-K49807096-003-02-3 BSPBio_003487 Benazepril (INN) Benazepril HCl Benazepril Hydrochloride Benazepril Sandoz Benazepril Sandoz (TN) Benazepril [INN:BAN] Benazeprilum Benazeprilum [Latin] Briem C06843 CGS-14824-A CHEBI:3011 CHEMBL838 CID5362124 Cibacen Cibacene D07499 DB00542 | Forteekor [veterinary] Forteekor [veterinary] (TN) KBio2_002457 KBio2_005025 KBio2_007593 KBio3_002707 KBioGR_000812 KBioSS_002464 LS-27973 Lotensin NCGC00165740-01 NCGC00165740-02 SPBio_000343 STK627447 Spectrum2_000482 Spectrum3_001674 Spectrum4_000286 Spectrum5_001546 Spectrum_001922 UNII-UDM7Q7QWP8 [(3S)-3-({(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid [(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid benazapril benazepril benzazepril |
| | 3 | | Hydrochlorothiazide | approved, vet_approved | Phase 4 | 413 | 58-93-5 | 3639 | 125727-50-6 3,4-Dihydro-6-chloro-7-sulfamyl-1,2, 4-benzothi 3,4-Dihydrochlorothiazide 58-93-5 6-Chloro-7-sulfamoyl-3, 4-dihy 8049-49-8 AB00052012 AC-11072 AC1L1GDT AC1Q55FM AF-614/30832002 AKOS000121373 ARONIS24316 Acesistem Acuilix Acuretic Aldactazide Aldactazide 25/25 Aldazida Aldectazide 50/50 Aldoril Ambap58-93-5 Apo-Hydro Apresazide Aquarills Aquarius Aquazide H Aquazide-H BAS 00371709 BIDD:GT0153 BPBio1_000019 BRD-K13078532-001-05-2 BRN 0625101 BSPBio_000017 BSPBio_002132 Bio-0714 Bremil Briazide C7H8ClN3O4S2 CAS-58-93-5 CCRIS 2082 CHEMBL435 CID3639 CPD000035778 Caplaril Capozide Carozide Catiazida Chlorizide Chlorosulthiadil Chlorothiazide Chlorsulfonamidodihydrobenzothiadiazine dioxide Chlorzide Chlothia Cidrex Clorana Component of Butizide Prestabs Concor Plus Condiuren D00340 D006852 DB00999 Diaqua Dichlorosal Dichlorotride Dichlothiazide Dichlotiazid Dichlotride Diclotride Dicyclotride Didral Dihydran Dihydrochlorothiazid Dihydrochlorothiazide Dihydrochlorothiazidum Dihydrochlorurit Dihydrochlorurite Dihydroxychlorothiazidum Direma Disalunil Disothiazid Diu 25 Vigt Diu-Melusin Diu-melusin Diuril Diurogen DivK1c_000289 Dixidrasi Drenol Dyazide EINECS 200-403-3 EU-0100614 Esidrex Esidrix Esidrix (TN) Esimil Esoidrina FT-0082750 Fluvin H 4759 H1274 H2910_SIAL H4759_SIAL HCT HCT-Isis HCTZ HCZ HMS1568A19 HMS1920D19 HMS2091L05 HMS500O11 HMS553N04 HSDB 3096 Hidril Hidro-Niagrin Hidrochlortiazid Hidroclorotiazida Hidroclorotiazida [INN-Spanish] Hidroronol Hidrosaluretil Hidrotiazida Hyclosid Hydrex-semi Hydril Hydro Par Hydro-Aquil Hydro-D Hydro-Diuril Hydro-Saluric Hydro-T Hydro-chlor HydroDIURIL Hydrochlorat Hydrochloro Thiazide Hydrochlorot Hydrochlorothiazid Hydrochlorothiazide Hydrochlorothiazide (JP15/USP/INN) Hydrochlorothiazide Intensol Hydrochlorothiazide [INN:BAN:JAN] | Hydrochlorothiazidum Hydrochlorothiazidum [INN-Latin] Hydrochlorthiazide Hydrochlorthiazidum Hydrocot Hydrodiuretic Hydrodiuril Hydropres Hydrosaluric Hydrothide Hydrozide Hydrozide Injection, Veterinary Hypothiazid Hypothiazide Hytrid Hyzaar I09-0531 IDI1_000289 Idroclorotiazide Idroclorotiazide [DCIT] Idrotiazide Inderide Inderide 80/25 Indroclor Ivaugan Jen-Diril KBio1_000289 KBio2_001357 KBio2_003925 KBio2_006493 KBio3_001352 KBioGR_000351 KBioSS_001357 LS-243 Lopac-H-4759 Lopac0_000614 Lopressor HCT Lotensin HCT Lotensin Hct MLS000069619 Manuril Maschitt Maxzide Maybridge Compound 10 Maybridge1_004336 Mazide 25 mg Medozide Megadiuril Microzide Microzide (TN) Mictrin Mikorten Modurcen Moduretic MolPort-000-144-465 NCGC00015508-01 NCGC00015508-02 NCGC00015508-03 NCGC00015508-07 NCGC00015508-12 NCGC00021906-03 NCGC00021906-04 NCGC00021906-05 NCGC00021906-06 NCGC00021906-07 NCGC00021906-08 NCI-C55925 NCI60_004317 NINDS_000289 NSC 53477 NSC53477 Natrinax Nefrix Nefrol Neo-Codema Neo-Flumen Neo-Minzil Neo-codema Neoflumen Newtolide Novodiurex Oprea1_357174 Oretic Pantemon Panurin Prestwick0_000009 Prestwick1_000009 Prestwick2_000009 Prestwick3_000009 Prestwick_263 Prinzide Raunova Plus Ro-Hydrazide Ro-hydrazide Roxane S1708_Selleck SAM002554901 SMR000035778 SPBio_001259 SPBio_001938 SPECTRUM1500335 STK315354 Saldiuril Sectrazide Selozide Ser-Ap-Es Servithiazid Spectrum2_001040 Spectrum3_000456 Spectrum4_000006 Spectrum5_000824 Spectrum_000877 Spironazide Su 5879 Tandiur Thiaretic Thiuretic Thlaretic Timolide UNII-0J48LPH2TH Unazid Unipres Urodiazin Urozide Vaseretic Vetidrex WLN: T66 BSWM EM DHJ HG ISZW ZINC00896569 Ziac Zide adiazine-1,1-dioxide component of Aldactazide component of Aldoril component of Caplaril component of Cyclex component of Dyazide component of Esimil diclot ride dro-2H-1,2,4-benzothiadiazine 1,1-dioxide hydrochlorothiazide panurin dichloride | |
| | 4 | | Dexmedetomidine | approved, vet_approved | Phase 4 | 592 | 76631-46-4, 113775-47-6 | 68602, 5311068, 56032 | (+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole (+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole (+)-medetomidine (S)-medetomidine 113775-47-6 4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole 4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole 5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole AC1NSJXT C07450 CHEBI:4466 CHEMBL778 CID5311068 D00514 DEXMEDETOMIDINE | Dexdor (T) Dexmedetomidin Dexmedetomidina Dexmedetomidine Dexmedetomidine (USAN/INN) Dexmedetomidinum Dexmédétomidine MPV 1440 MPV-1440 Medetomidina [Spanish] Medetomidine Medetomidinum [Latin] NCGC00025347-01 PRECEDEX Precedex (TN) Tocris-2023 ZINC04632106 |
| | 5 | | Pitavastatin | approved | Phase 4 | 66 | 147511-69-1, 147526-32-7 | 6366718, 5282452 | ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid (3R,5S,6E)-7-(2-Cyclopropyl-4-(p-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid 111GE002 147511-69-1 147526-32-7 2C25H23FNO4.Ca AC1NR03G AC1NR03J AKOS005145916 Alipza Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt C13334 CCRIS 8652 CID5282451 CID5282452 D01862 Itavastatin Itavastatin calcium KS-1220 LS-190698 | LS-74594 LS-74595 Livalo Livalo (TN) Livalo, Pitavastatin calcium Livazo MolPort-006-822-984 NK 104 NK-104 NKS-104 Nisvastatin P 872441 P-872441 Pitavastatia Pitavastatin Pitavastatin [INN] Pitavastatin calcium Pitavastatin calcium (JAN) Pitavastatin hemicalcium Pitavastatine Pitavastatinum S1759_Selleck ZINC01534965 calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate | |
| | 6 | | Ranibizumab | approved | Phase 4 | 486 | 347396-82-1 | 459903 | 347396-82-1 D05697 Lucentis Lucentis (TN) | Ranibizumab Ranibizumab (USAN/INN) Ranibizumab (genetical recombination) Ranibizumab (genetical recombination) (JAN) ranibizumab rhuFab V2 |
| | 7 | | Diltiazem | approved | Phase 4, Phase 3 | 77 | 42399-41-7 | 39186 | (+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester (+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester (2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate (2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate (2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate (2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate (2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one (2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one 144604-00-2 33286-22-5 42399-41-7 AC-936 AC1L2181 AC1Q6LHX Acalix Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester Adizem Aldizem Altiazem Anginyl Angizem Anoheal Apo-Diltiaz BIDD:GT0548 BPBio1_000230 BRD-K24023109-001-02-5 BRD-K24023109-003-03-9 BRN 3573079 BSPBio_000208 BSPBio_001311 Bio1_000371 Bio1_000860 Bio1_001349 Britiazim Bruzem C06958 C22H26N2O4S CHEBI:101278 CHEMBL23 CID39186 Calcicard Cardil Cardizem Cardizem (Hydrochloride) Cardizem CD Cardizem SR Cardizen LA Cartia XT Citizem Cormax D-cis-Diltiazem D07845 DB00343 Deltazen Dilacor Dilacor-XR Diladel Dilcontin | Dilpral Dilren Dilrene Dilt-cd Dilta-Hexal Diltia Diltiazem Diltiazem (INN) Diltiazem [INN:BAN] Diltiazemum Diltiazemum [INN-Latin] Dilticard Diltzac Dilzem Dilzen EINECS 255-796-4 Endrydil FT-0081415 HMS1791B13 HMS1989B13 HMS2089H09 HSDB 6528 Herbesser Incoril AP LS-40510 Lopac0_000327 MK-793 (Malate) Masdil MolPort-002-509-369 NCGC00024309-02 NCGC00024309-04 NCGC00024309-05 NCGC00024309-06 NCGC00024309-07 NCGC00024309-08 NCGC00024309-09 NCGC00024309-10 Novo-Diltazem Nu-Diltiaz Prestwick0_000134 Prestwick1_000134 Prestwick2_000134 Prestwick3_000134 RG 83606 (Hydrochloride) SPBio_002147 STOCK1N-03672 Surazem (TN) Syn-Diltiazem Tiamate Tiazac Tiazac Tildiem Tiazac XC Tocris-0685 UNII-EE92BBP03H Viazem [(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate d-cis-Diltiazem diltiazem nchembio.368-comp1 | |
| | 8 | | Valsartan | approved, investigational | Phase 4 | 295 | 137862-53-4 | 60846 | (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid (S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid 137862-53-4 AC-4543 AC1L1U1M AC1Q5QIK Ambap137862-53-4 Aventis brand of valsartan BIDD:GT0345 BRD-K45158365-001-02-3 BSPBio_003501 Bio-0796 C081489 C24H29N5O3 CEPA brand of valsartan CGP 48933 CGP-48933 CHEBI:9927 CHEMBL1069 CID60846 CPD000466318 D00400 DB00177 Diovan Diovan (TN) Diovan, Valsartan Esteve brand of valsartan HMS1922L21 HMS2051L12 HMS2093K22 HSDB 7519 KBio2_002287 KBio2_004855 KBio2_007423 KBio3_003006 KBioGR_001078 KBioSS_002289 | Kalpress L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI) LS-161334 Lacer brand of valsartan MLS000759423 MLS001424088 Miten MolPort-002-507-854 MolPort-003-666-608 N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine Nisis Nisis|| Novartis brand of valsartan Provas S1894_Selleck SAM001246581 SMR000466318 SPBio_001260 SPECTRUM1505209 Sanol brand of valsartan Schwarz brand of valsartan Spectrum2_001120 Spectrum3_001831 Spectrum4_000749 Spectrum5_001582 Spectrum_001796 TL8000869 Tareg UNII-80M03YXJ7I Vals Valsarran Valsartan (JAN/USAN/INN) Valsartan [USAN:INN] valsartan walsartan |Tareg |
| | 9 | | Calcium acetate | approved | Phase 4 | 20 | 62-54-4 | | Acetate OF lime Brown acetate of lime Ca(oac)2 | Gray acetate of lime Lime acetate Lime pyrolignite calcium ethanoate calcium(II) acetate |
| | 10 | | Primaquine | approved | Phase 4 | 76 | 90-34-6 | 4908 | ()-Primaquine (+)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine (+)-Primaquine (+/-)-Primaquine (-)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine (-)-Primaquine 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)- (9CI) 4-22-00-05817 (Beilstein Handbook Reference) 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine 6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline 6-Methoxy-8-[(4-amino-1-methylbutyl)amino]quinoline 6-Methoxy-8-[4-amino-1-methylbutylamino]quinoline 63-45-6 63-45-6 (1:2 PO4) 8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline 8-(4-Amino-1-m 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline 8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline 90-34-6 AB00053529 AC1L1J80 AC1Q4F0C AC1Q4F4Q BPBio1_000674 BRN 0019337 BSPBio_000612 BSPBio_002223 C07627 CCRIS 4109 CHEBI:8405 CHEMBL506 CID4908 D08420 DB01087 DivK1c_000806 EINECS 201-987-2 HMS2090J17 HSDB 6516 I08-0048 IDI1_000806 KBio1_000806 KBio2_001310 KBio2_003878 KBio2_006446 KBio3_001723 KBioGR_000967 KBioSS_001310 Kanaprim Kanaprim (TN) LS-141312 MolPort-001-794-628 | N(4)-(6-methoxyquinolin-8-yl)pentane-1,4-diamine N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine NCGC00178754-01 NCGC00178754-02 NCI60_001035 NCI60_005887 NINDS_000806 NSC 27296 NSC27296 Neo-Quipenyl Neo-quipenyl N~4~-[6-(methyloxy)quinolin-8-yl]pentane-1,4-diamine Oprea1_546209 PQ PRIMAQUINE Prestwick0_000476 Prestwick1_000476 Prestwick2_000476 Prestwick3_000476 Primachin Primachina Primachina [DCIT] Primachinum Primaquin Primaquina Primaquina [INN-Spanish] Primaquine (INN) Primaquine Bis-Phosphoric Acid Primaquine [INN:BAN] Primaquinum Primaquinum [INN-Latin] Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy Quinoline, 8-[(4-amino-1-methylbutyl)amino]-6-methoxy- (6CI,8CI) S. N. 13272 SMP1_000263 SN 13,272 SN 13272 SPBio_000674 SPBio_002551 STOCK5S-90838 Spectrum2_000887 Spectrum3_000552 Spectrum4_000484 Spectrum5_001363 Spectrum_000830 TG1-296 TG1-297 UNII-MVR3634GX1 WLN: T66 BNJ HO1 JMY1&3Z WR 2975 dl-Primaquine ethylbutylamino)-6-methoxyquinoline |
| | 11 | | Glimepiride | approved | Phase 4 | 234 | 93479-97-1 | 3476 | 1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea 1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea 3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide 3-ethyl-4-methyl-n-(4-(n-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide 64598P 93479-97-1 AB00513874 AC-476 AC1L1G0T Amarel Amaryl Amaryl (TN) Amaryl, Glista OD, Glimepiride Avaglim BPBio1_000751 BRD-K34776109-001-03-4 BRD-K42693031-001-01-8 BRN 5365754 BSPBio_000681 Bio-0049 C07669 C24H34N4O5S CAS-93479-97-1 CCRIS 7083 CHEBI:5383 CHEMBL1481 CID3476 CPD000466368 D00593 DB00222 Endial G2295_SIGMA Glimepirid Glimepirida Glimepirida [Spanish] Glimepiride (JAN/USP/INN) Glimepiride [USAN:BAN:INN] Glimepiridum Glimepiridum [Latin] | Glimepride Glimer Glimépiride Glymepirid HMS1570C03 HMS2052L03 HMS2090K18 HOE 490 Hoe-490 I06-0029 I06-2285 LS-136752 MLS000759495 MLS001076674 MLS001401419 MolPort-003-847-587 MolPort-003-987-461 MolPort-005-941-721 NCGC00016960-01 NCGC00161404-01 NCGC00161404-02 NCGC00181757-01 Novo-glimepiride Oprea1_382896 PMS-glimepiride Prestwick0_000651 Prestwick1_000651 Prestwick2_000651 Prestwick3_000651 Ratio-glimepiride Roname S1344_Selleck SAM001246710 SMR000466368 SPBio_002602 Sandoz glimepiride Solosa TL8005924 UNII-6KY687524K ZINC00537791 glimepiride | |
| | 12 | | Metformin | approved | Phase 4 | 1803 | 657-24-9 | 14219, 4091 | 1,1-Dimethyl biguanide 1,1-Dimethylbiguanide 3-(diaminomethylidene)-1,1-dimethylguanidine 657-24-9 AC1L1HE4 AKOS000121065 Apo-Metformin BIDD:GT0697 BPBio1_000009 BRD-K79602928-003-04-1 BSPBio_000007 BSPBio_002314 C07151 C4H11N5 CAS-1115-70-4 CCRIS 9321 CHEBI:6801 CHEMBL1431 CID4091 D04966 DB00331 DMGG Diabetosan Diabex Dimethylbiguanid Dimethylbiguanide Dimethylbiguanidine Dimethyldiguanide Dimethylguanylguanidine EINECS 211-517-8 Fluamine Flumamine Fortamet Gen-Metformin Glifage Gliguanid Glucophage Glucophage XR Glumetza Glycon HMS2089D19 HSCI1_000295 Haurymelin Haurymellin Islotin KBio2_002310 KBio2_004878 KBio2_007446 KBio3_002790 KBioGR_002310 | KBioSS_002312 LA-6023 LS-43899 Melbin Metformin Metformin (USAN/INN) Metformin HCL Metformin [USAN:INN:BAN] Metformina Metformina [DCIT] Metformina [Spanish] Metformine Metformine [INN-French] Metformine pamoate Metforminum Metforminum [INN-Latin] Metiguanide MolPort-002-929-560 MolPort-004-288-389 MolPort-005-767-418 Mylan-Metformin N,N-Dimethylbiguanide N,N-Dimethyldiguanide N,N-Dimethylimidodicarbonimidic diamide N,N-dimethylimidodicarbonimidic diamide N1,N1-Dimethylbiguanide NCGC00016564-01 NCGC00016564-02 NCGC00016564-03 NNDG Novo-Metformin Nu-Metformin PMS-Metformin Prestwick0_000004 Prestwick1_000004 Prestwick2_000004 Prestwick3_000004 Ran-Metformin Ratio-Metformin Riomet S2483_Selleck SPBio_001928 STK011633 Sandoz Metformin Siofor T5895664 Teva-Metformin UNII-9100L32L2N ZINC12859773 cMAP_000016 metformin metformin hydrochloride |
| | 13 | | Morphine | approved, investigational | Phase 4 | 1007 | 57-27-2 | 5288826 | (-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (-)-Heroin hydrochloride (-)-Morphine (-)Morphine sulfate (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol (5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol (5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL (7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol (−)-morphine 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol 4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol 4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol 47106-99-0 57-27-2 6211-15-0 (sulfate (2:1) (salt) pentahydrate) 64-31-3 64-31-3 (sulfate (2:1) (salt) anhydrous) 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol 7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol 8053-16-5 85201-37-2 Apokyn Astramorph PF Avinza BIDD:GT0147 C01516 CCRIS 5762 CHEBI:17303 CHEMBL70 CID5288826 Cube juice D-(-)-Morphine DB00295 DEA No. 9300 DepoDur Depodur Diacetylmorphine hydrochloride Diamorphine hydrochloride Dolcontin Dreamer Dulcontin Duramorph PF Duromorph EINECS 200-320-2 Epimorph HSDB 2134 Hard stuff Heroin hydrochloride Heroine hydrochloride Hocus | Infumorph Kadian LS-91748 M-Eslon M.O.S MOI MORPHINE SULFATE MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE MS Contin MS/L MS/S MSIR Meconium MolPort-003-849-273 Morfina Morfina [Italian] Morphia Morphin Morphin [German] Morphina Morphina [Italian] Morphine Extra-Forte Morphine Forte Morphine H.P Morphine Sulfate Morphine [BAN] Morphinism Morphinum Morphitec Morphium Morpho Moscontin Ms Contin Ms Emma NSC11441 Nepenthe O,O'-Diacetylmorphine hydrochloride OMS Concentrate Oramorph SR Ospalivina RMS RMS Uniserts Rescudose Roxanol Roxanol 100 Roxanol UD SDZ 202-250 SDZ202-250 Statex Statex Drops Statex SR UNII-76I7G6D29C Unkie l-Morphine morfina morphine nchembio.317-comp1 nchembio.64-comp1 |
| | 14 | | Norepinephrine | approved | Phase 4 | 699 | 51-41-2 | 439260 | (-)-(R)-Norepinephrine (-)-Arterenol (-)-Arterenol free base (-)-NORADRENALINE (-)-Noradrenaline (-)-Norepinephrine (-)-alpha-(Aminomethyl)protocatechuyl alcohol (R)-(-)-Norepinephrine (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol (R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol (R)-Noradrenaline (R)-Norepinephrine 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI) 4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol 4899-05-2 51-40-1 (l-tartrate (1:1)) 51-41-2 66197-73-7 A7257_SIGMA AC1L96ZT ALBB-006229 Adrenor Aktamin Arterenol BRN 4231961 BSPBio_002079 C00547 CHEBI:18357 CHEMBL1437 CID439260 D-(-)-Noradrenaline D00076 D53D5E3A-2360-4CA9-8031-6C2CD4062FD5 DB00368 DivK1c_000230 EINECS 200-096-6 HMS1920B08 HMS2089E18 HMS2091J08 HMS500L12 IDI1_000230 KBio1_000230 KBio2_001489 KBio2_004057 KBio2_006625 KBio3_001579 KBioGR_000635 KBioSS_001489 L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol L-3,4-Dihydroxyphenylethanolamine L-3,4-dihydroxyphenylethanolamine L-Arterenol L-Noradrenaline L-Norepinephrine L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol L-arterenol L-noradrenaline LS-42676 LT03330026 | LT4 Levarterenol Levarterenolo Levarterenolo [DCIT] Levoarterenol Levonor Levonoradrenaline Levonorepinephrine Levophed NCGC00159406-02 NCGC00159406-03 NCGC00159406-04 NCGC00159406-05 NCGC00159406-06 NCGC00159406-07 NCGC00159406-09 NINDS_000230 Nor adrenalin Nor adrenalin (TN) Nor-Epirenan Nor-adrenaline Noradrenalin Noradrenalina Noradrenalina [Italian] Noradrenaline Noradrenaline (JP15) Noradrenalinum Norartrinal Noreinefrina Noreinefrina [INN-Spanish] Norepinefrina Norepinephrine Norepinephrine (INN) Norepinephrine Noradrenalin Norepinephrine [INN:JAN] Norepinephrine l-Tartrate (1:1) Norepinephrinum Norepinephrinum [INN-Latin] Norepirenamine PDSP1_001111 PDSP2_001095 SGCUT00123 SPBio_001048 SPECTRUM1500436 STK503776 Spectrum2_001064 Spectrum3_000520 Spectrum4_000078 Spectrum5_001068 Spectrum_001009 Sympathin E UNII-X4W3ENH1CV bmse000404 l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol nchembio.284-comp2 nchembio.64-comp2 nchembio705-1 noradrenaline norepinefrina norepinephrine norepinephrinum to_000024 | |
| | 15 | | Dopamine | approved | Phase 4, Phase 3 | 3836 | 51-61-6, 62-31-7 | 681 | (3H)-Dopamine .Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI) 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium 153C5321-5FEE-4B0B-8925-F388F0EEEBD1 2-(3,4-Dihydroxyphenyl)ethylamine 2-(3,4-dihydroxyphenyl)ethylamine 2-benzenediol 3,4-Dihydroxyphenethylamine 3,4-Dihydroxyphenethylamine hydrochloride 3,4-Dihydroxyphenylethylamine 3,4-dihydroxyphenethylamine 3-Hydroxtyramine 3-Hydroxytyramine 3-Hydroxytyramine Hydrobromide 3-Hydroxytyramine hydrochloride 4-(2-Aminoethyl)-1, 4-(2-Aminoethyl)-1,2-benzenediol 4-(2-Aminoethyl)-1,2-bezenediol 4-(2-Aminoethyl)-Pyrocatechol 4-(2-Aminoethyl)benzene-1,2-diol 4-(2-Aminoethyl)catechol 4-(2-Aminoethyl)pyrocatechol 4-(2-Aminoethyl)pyrocatechol hydrochloride 4-(2-aminoethyl)-pyrocatechol 50444-17-2 51-61-6 62-31-7 (HYDROCHLORIDE) AC1L19S5 AC1Q54AX AC1Q54AY AKOS003790978 ASL 279 BIDD:ER0506 BPBio1_001123 BSPBio_001932 Biomol-NT_000001 C03758 CHEBI:18243 CHEMBL59 CID681 D07870 DB00988 Deoxyepinephrine DivK1c_000780 Dopamin Dopamina Dopamina [INN-Spanish] Dopamine Dopamine (INN) Dopamine (USAN)(*hydrochloride*) Dopamine [INN:BAN] Dopaminum Dopaminum [INN-Latin] Dopastat Dophamine Dynatra EINECS 200-110-0 HSDB 3068 Hydroxytyramin Hydroxytyramine IDI1_000780 IP 498 Intropin Intropin [*hydrochloride*] KBio1_000780 | KBio2_001492 KBio2_002388 KBio2_002484 KBio2_004060 KBio2_004956 KBio2_005052 KBio2_006628 KBio2_007524 KBio2_007620 KBio3_001152 KBio3_002867 KBio3_002962 KBioGR_001129 KBioGR_002388 KBioGR_002484 KBioSS_001492 KBioSS_002393 KBioSS_002491 KW-3-060 L-DOPAMINE L000232 LDP LS-159 Lopac-H-8502 Lopac0_000586 Medopa (TN) MolPort-001-641-000 NCGC00015519-01 NCGC00015519-08 NCGC00096050-01 NCGC00096050-02 NCGC00096050-03 NCGC00096050-04 NCGC00096050-05 NINDS_000780 NSC 173182 NSC169105 NSC173182 Oprea1_088821 Oxytyramine Pyrocatechol, 4-(2-aminoethyl)- (8CI) Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride Revimine Revivan SPBio_001205 SPECTRUM1505155 ST048774 STK301601 Spectrum2_001023 Spectrum3_000406 Spectrum4_000525 Spectrum5_000945 Spectrum_001012 UNII-VTD58H1Z2X UPCMLD0ENAT5885989:001 a-(3,4-Dihydroxyphenyl)-b-aminoethane alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane cMAP_000036 cMAP_000065 dopamine hydroxytyramine intropin m-Hydroxytyramine hydrochloride nchembio.105-comp9 nchembio.107-comp4 nchembio.284-comp1 nchembio.78-comp16 nchembio.89-comp3 nchembio705-8 nchembio801-comp8 |
| | 16 | | Fluoxetine | approved, vet_approved | Phase 4 | 238 | 54910-89-3 | 3386 | (+) or (-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine (+) or (-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine (+/-)-Fluoxetine (+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine (+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine (+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine (+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine] (+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine 3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine 52341-67-0 54910-89-3 57226-07-0 59333-67-4 (hydrochloride) AB00053774 AC-14564 AC1L1FTH AKOS003663021 Adofen Animex-On BPBio1_000354 BPBio1_000509 BRD-A31159102-001-01-9 BRD-A31159102-003-05-6 BSPBio_000461 BSPBio_003375 Bio-0787 Biomol-NT_000152 C17H18F3NO CHEBI:5118 CHEMBL41 CID3386 D00326 DB00472 Deprex DivK1c_006819 Eufor Floxetine Fluctin Fluoxeren Fluoxetin Fluoxetina Fluoxetina [INN-Spanish] Fluoxetina [Spanish] Fluoxetine (TN) Fluoxetine (USAN/INN) Fluoxetine Hcl Fluoxetine Hydrochloride Fluoxetine [USAN:INN:BAN] Fluoxetinum | Fluoxetinum [INN-Latin] Fluoxétine Fluval Fontex Foxetin HMS2090H14 KBio1_001763 KBio2_002159 KBio2_004727 KBio2_007295 KBio3_002595 KBioGR_001166 KBioSS_002159 L000931 LS-31040 Lilly-110140 Lopac0_000558 Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine MolPort-001-683-482 N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine NCGC00015428-10 NCGC00024879-03 NCGC00024879-04 NSC283480 Portal Prestwick0_000511 Prestwick1_000511 Prestwick2_000511 Prestwick3_000511 Prozac Prozac Weekly Pulvules Reconcile Reneuron SPBio_001815 SPBio_002382 STK734483 Sarafem SpecPlus_000723 Spectrum2_001658 Spectrum3_001648 Spectrum4_000613 Spectrum5_001518 Spectrum_001679 TL8003595 UNII-01K63SUP8D dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine fluoxetine fluoxetine (Prozac) nchembio.534-comp2 |
| | 17 | | Zinc | approved | Phase 4 | 2296 | 7440-66-6 | 32051, 23994 | | | 18 | | Sevelamer | approved | Phase 4 | 74 | 52757-95-6, 152751-57-0 | 3085017 | | Sevelamero Sevelamerum Sévélamer |
| | 19 | | Sirolimus | approved, investigational | Phase 4, Phase 2 | 1940 | 53123-88-9 | 5284616, 6436030, 46835353 | (-)-Rapamycin (-)-rapamycin 1fkb 1pbk 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 53123-88-9 A422989, NSC226080 AC-722 AC1L1JH9 AC1L7MJ9 AC1L9ZMV AY 22989 AY-22989 AY22989 Ambotz53123-88-9 Antibiotic AY 22989 BIDD:PXR0165 Bio1_000293 Bio1_000782 Bio1_001271 Bio2_000375 Bio2_000855 BiomolKI2_000084 C07909 C51H79NO13 CBiol_002007 CCRIS 9024 CHEBI:100923 CHEBI:9168 CHEMBL413 CID10213190 CID10795871 CID11949238 CID11959112 CID313006 CID478951 CID5040 CID5284616 CID5358081 CID5374464 CID5460439 CID5497196 CID5924240 CID6436030 CID6610270 CID6610346 CID6711160 CID6713081 CID9833581 CID9854379 CID9854380 CID9962926 CID9962928 D00753 DB00877 DE-109 DivK1c_006936 | FT-0082351 HMS2089A21 HSDB 7284 KBio1_001880 KBio2_000410 KBio2_002978 KBio2_005546 KBio3_000779 KBio3_000780 KBioGR_000410 KBioSS_000410 LCP-Siro LMPK06000003 LS-143290 MLS000028373 MS-R001 MolMap_000043 MolPort-003-959-433 NCGC00021305-05 NCI60_001851 NCIMech_000355 NSC 226080 NSC226080 Perceiva QTL1_000069 R0395_SIAL R0395_SIGMA RAP RAPA RPM Rapammune Rapamune Rapamune (TN) Rapamycin Rapamycin (TN) Rapamycin C-7, analog 4 Rapamycin Immunosuppressant Drug Rapamycin from Streptomyces hygroscopicus S1039_Selleck SIIA 9268A SILA 9268A SILA9268A SMP1_000255 SMR000058564 Sirolimus Sirolimus (RAPAMUNE) Sirolimus (USAN/INN) Sirolimus [USAN:BAN:INN] Sirolimus, Rapamune,Rapamycin SpecPlus_000840 UNII-W36ZG6FT64 UNM-0000358684 WY-090217 Wy 090217 heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy nchembio.100-comp4 nchembio.2007.42-comp2 nchembio.79-comp1 nchembio762-comp1 nchembio883-comp3 rapamycin sirolimus |
| | 20 | | Mycophenolate mofetil | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 952 | 128794-94-5 | 5281078 | 115007-34-6 128794-94-5 140401-05-4 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E) AC-1562 AC1NQXZW AC1Q6O6X AR-1J6939 BB_NC-2566 C07908 C23H31NO7 CHEMBL1456 CID5281078 CellCept CellCept, RS 61443, TM-MMF, Mycophenolate mofetil Cellcept Cellcept (TN) D00752 DB00688 HMS2090A03 | HSDB 7436 I01-0898 I06-1947 LS-172272 LS-75572 ME-MPA MMF MMF CellCept(TM) MolPort-000-883-800 Munoloc Mycophenolate mofetil (JAN/USAN) Mycophenolic acid morpholinoethyl ester Mycophenylate mofetil NCGC00159459-02 NCGC00159459-03 NSC724229 R-99 RS 61443 RS-61443 RS-61443-190 S1501_Selleck TL8000648 TM-MMF UNII-9242ECW6R0 ZINC21297660 mycophenolate mofetil | |
| | 21 | | Mycophenolic acid | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 952 | 24280-93-1 | 446541 | (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid Acide mycophenolique Acido micofenolico Acidum mycophenolicum | Melbex Micofenolico acido Mycophenoic acid Mycophenolate Mycophenolsäure Myfortic |
| | 22 | | Miconazole | approved, investigational, vet_approved | Phase 4, Phase 2 | 3706 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Micantin (nitrate) Miconasil Nitrate | Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole | |
| | 23 | | Everolimus | approved | Phase 4, Phase 2 | 1940 | 159351-69-6 | 6442177 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy 07741_FLUKA 159351-69-6 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-Hydroxyethyl)rapamycin Afinitor CERTICAN(R) CHEMBL1201755 Certican D02714 DB01590 | Everolimus Everolimus (JAN/USAN/INN) Everolimus [USAN] LS-143292 MolPort-003-847-342 MolPort-003-925-588 NCGC00167512-01 NVP-RAD-001 RAD 001 RAD-001 RAD-001C RAD001 RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus S1120_Selleck SDZ-RAD UNII-9HW64Q8G6G Zortress everolimus |
| | 24 | | Benzocaine | approved | Phase 4, Phase 3 | 2016 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 25 | | Mannitol | approved, investigational | Phase 4 | 280 | 69-65-8 | 453, 6251 | (2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol (2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol (L)-Mannitol 1,2,3,4,5,6-Hexanehexol 123897-58-5 133-43-7 15719_ALDRICH 15719_RIEDEL 33440_RIEDEL 33440_SIGMA 36413-61-3 4-01-00-02841 (Beilstein Handbook Reference) 5149-40-6 63559_FLUKA 63559_SIGMA 63560_FLUKA 63565_FLUKA 63565_SIGMA 69-65-8 75398-80-0 85085-15-0 87-78-5 AB1002081 AC-12776 AC1L1M49 AC1Q28E5 AI3-19511 AR-1J3861 Ambap69-65-8 BRN 1721898 C00392 C6H14O6 CCRIS 369 CHEBI:16899 CHEMBL689 CID6251 Cordycepate Cordycepic acid D-(-)-Mannitol D-Mannitol D-Mannitol (JP15) D-mannite D-mannitol D00062 D008353 DL-Mannitol Diosmol ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D EINECS 200-711-8 EINECS 201-770-2 Fraxinine HSDB 714 Hexahydroxyhexane Hexanhexol Invenex Isotol LS-1588 LS-89250 M0044 M1902_SIGMA M4125_SIAL M8429_SIAL M9546_SIAL M9647_SIAL MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45% | MANNITOL 25% MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12% MLS001335977 MLS001335978 MTL Manicol Manitol Maniton S Maniton-S Manna Sugar Manna sugar Mannazucker Mannidex Mannidex 16700 Mannigen Mannistol Mannit Mannit p Mannite Mannitol Mannitol (USP) Mannitol (VAN) Mannitol 10% Mannitol 10% In Plastic Container Mannitol 15% Mannitol 15% In Plastic Container Mannitol 20% Mannitol 20% In Plastic Container Mannitol 5% Mannitol 5% In Plastic Container Mannitol [USAN] Mannitolum Mannogem 2080 Marine Crystal Marine crystal MolPort-003-927-039 Mushroom sugar NCGC00164246-01 NCI-C50362 NSC 407017 NSC 9256 OSMITROL 10% IN WATER IN PLASTIC CONTAINER OSMITROL 15% IN WATER IN PLASTIC CONTAINER OSMITROL 20% IN WATER IN PLASTIC CONTAINER OSMITROL 5% IN WATER IN PLASTIC CONTAINER Osmitrol Osmitrol (TN) Osmitrol 10% In Water Osmitrol 15% In Water Osmitrol 20% In Water Osmitrol 5% In Water Osmofundin Osmosal Resectisol Resectisol In Plastic Container SDM No. 35 SMR000857324 SORBITOL-MANNITOL IN PLASTIC CONTAINER Sorbitol-Mannitol TL806434 UNII-3OWL53L36A ZINC02041302 bmse000099 cpd without stereochemical designation e 421 e-421 e421 manita mannitol |
| | 26 | | Heparin | approved, investigational | Phase 4 | 848 | 9005-49-6 | 772, 46507594 | 101921-26-0 102-94-3 102785-31-9 104521-37-1 11078-24-3 11129-39-8 12656-11-0 2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose 37324-73-5 6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid 9041-08-1 9045-22-1 9075-96-1 913079-23-9 91449-79-5 AC1L19ZN AC1L1ROY ALFA 87-120 ALFA 87-163 ALFA 87-198 ALFA 87-81 ALFA 88-247 AR-1E4539 Allocinnamic acid Ardeparin Ardeparin sodium Arteven Bemiparin Bemiparin sodium CID772 CID8784 CY 216 Calciparine Certoparin Clexane Clivarin Clivarine Cy 222 D006495 D017984 DB00407 DB01225 Dalteparin Dalteparin sodium Depo-Heparin EINECS 232-681-7 EMT 966 EMT 967 EMT-966 EMT-967 EMT966 EMT967 Enoxaparin Enoxaparin sodium Enoxaparine Eparina Eparina [DCIT] FR 860 Fluxum Fragmin A Fragmin B Fragmin IV Fraxiparin H 2149 HSDB 3094 Hed-heparin Hep Flush Kit in plastic container Hep-Lock Hep-Lock U/P Hep-lock Heparin Heparin CY 216 Heparin Lock Flush Heparin Lock Flush in plastic container Heparin Lock Flush preservative free Heparin Lock Flush preservative free in plastic container Heparin Sodium Heparin natrium Heparin sodium Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container Heparin sodium 1,000 units in dextrose 5% in plastic container Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container Heparin sodium 10,000 units in dextrose 5% Heparin sodium 10,000 units in dextrose 5% in plastic container Heparin sodium 10,000 units in sodium chloride 0.45% Heparin sodium 10,000 units in sodium chloride 0.9% Heparin sodium 12,500 units in dextrose 5% Heparin sodium 12,500 units in dextrose 5% in plastic container Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container Heparin sodium 12,500 units in sodium chloride 0.9% Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container Heparin sodium 2,000 units in dextrose 5% in plastic container Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container Heparin sodium 20,000 units and dextrose 5% in plastic container Heparin sodium 20,000 units in dextrose 5% in plastic container Heparin sodium 25,000 units and dextrose 5% in plastic container | Heparin sodium 25,000 units in dextrose 5% Heparin sodium 25,000 units in dextrose 5% in plastic container Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container Heparin sodium 25,000 units in sodium chloride 0.9% Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container Heparin sodium 5,000 units in dextrose 5% in plastic container Heparin sodium 5,000 units in sodium chloride 0.45% Heparin sodium 5,000 units in sodium chloride 0.9% Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container Heparin sodium in plastic container Heparin sodium preservative Free Heparin sulfate Heparin sulphate Heparin, Low Molecular Weight Heparin, Low-Molecular-Weight Heparin, sodium salt Heparina Heparina [INN-Spanish] Heparinate Heparine Heparine [INN-French] Heparinic acid Heparinsodiumsalt Heparinum Heparinum [INN-Latin] Heparinum natricum Hepathrom Hepflush-10 Inno-Hep Innohep Isocinnamic acid KB 101 Kabi 2165 LHN 1 LMWH Lioton 1000 Lipo-hepin Liquaemin Liquaemin Lock Flush Liquaemin Sodium Liquaemin sodium preservative free Liquemin Logiparin Lovenox Lovenox HP Low Molecular Weight Heparin Low molecular weight heparin Low molecular weight heparin sodium Low-Molecular-Weight Heparin Minolteparin sodium MolPort-003-760-257 Multiparin NSC174025 Nadroparin Nadroparine Novoheparin OP 386 OP 622 Octaparin PK 10,169 PK-10,169 PK-10169 PK10,169 PK10169 Pabyrin Panheprin Parnaparin Parnaparin sodium Parvoparin Pularin Reviparin Reviparin sodium Ro 11 Sandoparin Sodium acid heparin Sodium heparin Sodium heparinate Subeparin Sublingula Thromboliquine Tinzaparin Tinzaparin sodium Triofiban UNII-12M44VTJ7B UNII-3S182ET3UA UNII-E47C0NF7LV UNII-T2410KM04A UNII-ZZ45AB24CA Unfractionated heparin Vetren Vitrum AB WY 90493RD alpha-Heparin cis-.beta.-Carboxystyrene cis-Cinnamic acid enoxaparin heparin |
| | 27 | | Glucosamine | approved, Nutraceutical | Phase 4 | 191 | 3416-24-8 | 439213 | (+)-2-amino-2-deoxy-D-glucopyranose (2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol (2S,5R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol (3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol 14257-69-3 2-Amino-2-deoxy-D-Glucose 2-Amino-2-deoxy-D-glucopyranose 2-Amino-2-deoxy-D-glucose 2-Amino-2-deoxy-beta-D-glucopyranose 2-Amino-2-deoxyglucose 2-Aminoglucose 2-Deoxy-2-amino-D-glucose 2-Deoxy-2-aminoglucose 2-amino-2-deoxy-D-glucopyranose 2-amino-2-deoxyglucose 2351-15-7 28905-10-4 2B4D44B2-D5AC-4DA4-9BE6-A4AE9574E4A6 3416-24-8 4-04-00-02017 (Beilstein Handbook Reference) 58-87-7 58267-75-7 6490-70-6 880765-44-6 90-77-7 911653-84-4 AC1L2D1C AC1L96WB AC1L9B8P AC1Q4UBH BRN 1724602 BSPBio_002086 C00329 C08349 CHEBI:28393 CHEBI:47977 CHEMBL234432 CID18897 CID439213 CID441477 CPD0-1193 Chitosamine Cosamin D-(+)-Glucosamine | D-Glucosamine D-glucosamine D04334 DB01296 DivK1c_000261 EINECS 222-311-2 GCS Glucosamina Glucosamina [INN-Spanish] Glucosamine (USAN/INN) Glucosamine [USAN:INN] Glucosaminum Glucosaminum [INN-Latin] HMS500N03 HSDB 7469 IDI1_000261 InChI=1/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6-/m1/s1 KBio1_000261 KBio2_001311 KBio2_003879 KBio2_006447 KBio3_001306 KBioGR_000970 KBioSS_001311 LS-71671 MolPort-002-507-091 MolPort-003-944-937 NCGC00164421-01 NCGC00178826-01 NINDS_000261 SPBio_000477 STK801823 Spectrum2_000519 Spectrum3_000443 Spectrum4_000565 Spectrum5_000756 Spectrum_000831 Viartril-S beta-D-Glucosamine bmse000247 chitosamine glucosamine nchembio.189-comp4 nchembio.2007.41-comp7 nchembio.412-comp5 partially N-deacetylated poly-beta-1,6-N-acetyl-D-glucosamine |
| | 28 | | Ergocalciferol | approved, nutraceutical | Phase 4, Phase 3 | 1281 | 50-14-6 | 5280793 | 'Ergosterol irradiated' (+)-Vitamin D2 (3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol (3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol (3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol (3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol (3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol (3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol (5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol (5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol (5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol (5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol (5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol 22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol 31316-19-5 4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol 47768_SUPELCO 50-14-6 7489-18-1 7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87 8017-28-5 9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol 9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol 9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol 9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol 95220_FLUKA 95220_SIGMA AC-1355 AC1L1FIE AC1NQXLH AC1NS4DE AC1NS9GI AC1NSSVD AC1NWAM3 AC1O5EDK AC1O6WAM ACon1_002187 Activated ergosterol BPBio1_000418 BSPBio_000380 BSPBio_001974 Buco-D C05441 C28H44O CALCIFEROL IN A GELATIN MATRIX CALCIFEROL, U.S.P. CHEBI:28934 CHEMBL1536 CID11003810 CID3249 CID5280793 CID5315257 CID5353610 CID5356615 CID5702050 CID6432478 CID6536972 Calciferol Calciferol (TN) Calciferol (vitamin D2) Calciferolum Calciferon 2 Condacaps Condocaps Condol Crtron Crystallina D-Arthin D-Tracetten D00187 DB00153 Daral Davitamon D Davitin De-rat concentrate Decaps Dee-Osterol Dee-Ron Dee-Ronal Dee-Roual Deltalin Deratol Detalup Diactol Divit urto Doral Drisdol Drisdol (TN) E5750_SIGMA EINECS 200-014-9 Ercalciol Ergocalciferol Ergocalciferol (D2) Ergocalciferol (JP15/USP) Ergocalciferol [INN:BAN:JAN] Ergocalciferol oil Ergocalciferol: Vitamin D | Ergocalciferolo Ergocalciferolo [DCIT] Ergocalciferols Ergocalciferolum Ergocalciferolum [INN-Latin] Ergorone Ergosterol activated Ergosterol irradiated Ergosterol, irradiated Ertron Fortodyl Geltabs Geltabs Vitamin D HMS1920K20 HMS2091B19 HMS502I07 HSDB 819 Haliver Hi-Deratol Hyperkil I05-0022 IDI1_000805 Infron Irradiated ergosta-5,7,22-trien-3-beta-ol Irradiated ergosta-5,7,22-trien-3.beta.-ol Irradiated ergosta-5,7,22-trien-3beta-ol Irradiated ergosterol LMST03010001 LMST03010014 LS-3228 MEGxm0_000466 MLS001332467 MLS001332468 Metadee Mina D2 MolPort-001-740-057 MolPort-001-793-930 MolPort-002-526-645 MolPort-003-666-178 MolPort-006-822-629 Mulsiferol Mykostin NCGC00142497-01 NCGC00179579-01 NCGC00179579-02 NSC 62792 NSC62792 Novovitamin-D Oleovitamin D Oleovitamin D, Synthetic Oleovitamin D2 Osteil Ostelin Prestwick3_000420 Prestwick_554 Radiostol Radstein Radsterin Rodine C Rodinec SMR000857106 SPECTRUM1500276 ST057150 STOCK1N-53397 Shock-ferol Shock-ferol sterogyl Sorex C.R Sorex C.R. Spectrum5_000666 Sterogyl Synthetic Vitamin D UNII-VS041H42XC Uvesterol D Uvesterol-D VITAMIN D2 VITAMIN D2 WATER DISPERSABLE U.S.P. VITAMIN_D2 Vigantol Vio D Vio-D Viostdrol Viosterol Viosterol in Oil Vitamin D2 Vitamin- D2 Vitamin-?D2 Vitamina D2 Vitavel-D WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ ZINC04474571 ZINC04629876 beta-Ol bmse000510 component of Geltabs Vitamin D delta-Arthin delta-Tracetten ergocalciferol vitamin d-2 | |
| | 29 | | Calcitriol | approved, nutraceutical | Phase 4 | 210 | 32222-06-3 | 134070, 5280453 | (1R,3S)-5-{2-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol (1S,3R,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol (1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol (1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol (1α,3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol (3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol (5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol (5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1-alpha,3-beta,25-triol (5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol 1 alpha,25-Dihydroxyvitamin D3 1,25 (OH)2 D3 1,25 Dihydroxycholecalciferol 1,25(OH)2-20epi-D3 1,25(OH)2D3 & CD4 1,25(OH2)D3 1,25-(OH)2-D3 1,25-(OH)2D3 1,25-DHCC 1,25-DIHYDROXYCHOLECALCIFEROL 1,25-Dihydroxycholecalciferol 1,25-Dihydroxycholecaliferol 1,25-Dihydroxyvitamin D 1,25-Dihydroxyvitamin D3 1,25-dihydroxy vitamin D3 1,25-dihydroxy-20-epi-Vitamin D3 1,25-dihydroxycholecalciferol 1,25D3 1-alpha,-1,25-Dihydroxyvitamin D3 1-alpha,25-Dihydroxycholecalciferol 1-alpha,25-Dihydroxyvitamin D3 1-alpha-25-Dihydroxyvitamin D3 1-alpha-25-dihydroxyvitamin D3 1.Alpha.,25-Dihydroxy-26,27-hexadeuterovitamin D3 17936_FLUKA 17936_SIGMA 1a,25-(OH)2D3 1a,25-Dihydroxycholecalciferol 1a,25-Dihydroxyvitamin D3 1alpha,25(OH)2-D3 1alpha,25(OH)2D3 1alpha,25-Dihydroxycholecalciferol 1alpha,25-Dihydroxyvitamin D 1alpha,25-Dihydroxyvitamin D3 1db1 1α,25(OH)2D3 1α,25-dihydroxycholecalciferol 1α,25-dihydroxyvitamin D3 20-epi-1alpha,25-dihydroxycholecaliferol 25-Dihydroxycholecalciferol 32222-06-3 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha,3beta,25-triol 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)- & CD4 9,10-seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha, 3beta, 25-triol AC-1859 AC1NQX1S Ambap32222-06-3 | Asentar BCBcMAP01_000160 BML2-E03 BSPBio_001287 C01673 CCRIS 5522 CD-2027 CHEBI:17823 CHEMBL846 CID5280453 CPD000466393 Calcijex Calcijex, Silkis, Rocaltrol, Topitriol, Cholecalciferol,Calcitriol Calcitriol Calcitriol (JAN/USAN/INN) Calcitriol [USAN:INN:BAN:JAN] Calcitriolum Calcitriolum [INN-Latin] D00129 D1530_SIGMA DN 101 DN-101 Decostriol Dihydroxyvitamin D3 EINECS 250-963-8 HMS1361A09 HMS1791A09 HMS1989A09 HMS2051F06 HMS2089N03 HSDB 3482 IDI1_033757 LMST03020258 LS-53093 MC-1288 MC1288 MLS000759536 MLS001424122 MolPort-002-045-698 NCGC00161327-01 NCGC00161327-04 Ro 21-5535 Ro 215535 Ro-21-5535 Rocaltrol Rocaltrol (TN) S1466_Selleck SAM001246772 SMR000466393 Silkis Soltriol Spectrum5_002061 Topitriol Toptriol U 49562 Vectical ZINC03924790 calcitriol vit D |
| | 30 | | Niacin | approved, investigational, nutraceutical | Phase 4 | 923 | 59-67-6 | 938 | 3-Carboxylpyridine 3-Carboxypyridine 3-Pyridinecarboxylate 3-Pyridinecarboxylic acid 3-Pyridylcarboxylate 3-Pyridylcarboxylic acid 3-carboxypyridine Acide Nicotinique Acido nicotinico Acidum Nicotinicum Akotin Anti-pellagra vitamin Apelagrin Daskil Efacin Enduracin Linic M-Pyridinecarboxylic Acid Niac Niacin Niacine Niacor Nicacid Nicamin Nicangin | Nico-Span Nicobid Nicocap Nicodelmine Nicolar Niconacid Nicosan 3 Nicotinate Nicotinic Acid Nicotinic acid Nicotinipca Nicyl Nikotinsaeure Nyclin P.P. factor PP Factor Pellagra preventive factor Pellagrin Pelonin Pyridine-beta-carboxylic acid Slo-niacin Vitamin B3 Wampocap beta-Pyridinecarboxylic acid pyridine-β-carboxylic acid β-pyridinecarboxylic acid | |
| | 31 | | tannic acid | approved, Nutraceutical | Phase 4, Phase 3 | 2016 | | | | 32 | | Nicotinamide | approved, Nutraceutical | Phase 4 | 919 | 98-92-0 | 936 | .beta.-Pyridinecarboxamide 11032-50-1 123574-63-0 1yc5 3 Pyridinecarboxamide 3-Carbamoylpyridine 3-Pyridinecarboxamide 3-Pyridinecarboxylic acid amide 37321-14-5 47865U_SUPELCO 55600-01-6 63748-44-7 72340_FLUKA 72340_SIGMA 72347_FLUKA 78731-47-2 98-92-0 A186B02E-6C70-4E54-9739-79398D439AAA AC-907/25014114 AC1L1ACZ AC1Q4ZFV AI3-02906 Acid amide Amid kyseliny nikotinove Amid kyseliny nikotinove [Czech] Amide PP Aminicotin Amixicotyn Amnicotin Astra Brand of Niacinamide Austrovit PP B 3, Vitamin B3, Vitamin BB_NC-2290 Benicot C00153 C6H6N2O CCRIS 1901 CHEBI:17154 CHEMBL1140 CID936 CPD000058212 D00036 D009536 DB02701 DEA No. 1405 Delonin Amide Delonin amide Dipegyl Dipigyl EINECS 202-713-4 EINECS 234-265-0 Endobion Enduramide Factor pp HMS2052M21 HMS2090B05 HMS2093H03 HSDB 1237 Hansamid I02-1741 I02-2250 InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9 Inovitan PP Jenapharm Brand of Niacinamide Jenapharm, Nicotinsaureamid LS-2051 MLS000069714 Mediatric Merck Brand of Niacinamide MolMap_000061 MolPort-001-783-876 N0078 N0636_SIGMA N2142_SIGMA N3376_SIGMA N5535_SIAL NAM NCGC00093354-03 NCGC00093354-04 NSC 13128 NSC13128 NSC27452 Nandervit-N Niacevit Niacinamide Niacinamide (USP) Niacinamide Astra Brand Niacinamide Jenapharm Brand Niacinamide Merck Brand | Niacinamide Pharmagenix Brand Niacinamide [USAN] Niacinamide, Nicotinic acid amide, Nicotinamide Niacotinamide Niamide Niavit PP Nicamide Nicamina Nicamindon Nicasir Nicobion Nicofort Nicogen Nicomidol Nicosan 2 Nicosylamide Nicota Nicotamide Nicotilamide Nicotililamido Nicotinamid Nicotinamida Nicotinamida [INN-Spanish] Nicotinamide Nicotinamide (JP15/INN) Nicotinamide (Niacinamide) Nicotinamide, niacin, vitamin B3 Nicotinamide-carbonyl-14C Nicotinamidum Nicotinamidum [INN-Latin] Nicotine acid amide Nicotine amide Nicotinic acid amide Nicotinic amide Nicotinsaeureamid Nicotinsaureamid Nicotinsaureamid Jenapharm Nicotinsaureamid [German] Nicotol Nicotylamide Nicotylamidum Nicovel Nicovit Nicovitina Nicovitol Nicozymin Nictoamide Nikasan Nikazan Niko-tamin Nikotinamid Nikotinsaeureamid Nikotinsaeureamid [German] Niocinamide Niozymin PP-Faktor Papulex Pelmin Pelmine Pelonin amide Pharmagenix Brand of Niacinamide Propamine A Pyridine-3-carboxylic acid amide S1899_Selleck SAM001246860 SGCUT00176 SMR000058212 Savacotyl UNII-25X51I8RD4 Vi-Nicotyl Vi-noctyl Vitamin B Vitamin B (VAN) Vitamin B 3 Vitamin B3 amide Vitamin H1 Vitamin PP WLN: T6NJ CVZ Witamina PP ZINC00005878 b-Pyridinecarboxamide beta-Pyridinecarboxamide bmse000281 m-(Aminocarbonyl)pyridine nchembio.154-comp4 nchembio.73-comp6 niacin - Vitamin B3 niacinamide nicotinamide pyridine-3-carboxamide to_000073 vitamin PP |
| | 33 | | Antimalarials | | Phase 4 | 1246 | | | | 34 | | Artemisinins | | Phase 4 | 289 | | | | 35 | | Artemisinine | | Phase 4 | 289 | | | | 36 | | Antiparasitic Agents | | Phase 4 | 2199 | | | | 37 | | Antiprotozoal Agents | | Phase 4 | 2051 | | | | 38 | | Neurotransmitter Uptake Inhibitors | | Phase 4, Phase 3 | 3521 | | | | 39 | | Dopamine Agents | | Phase 4, Phase 3 | 3836 | | | | 40 | | Antifungal Agents | | Phase 4, Phase 2 | 3696 | | | | 41 | | Antidepressive Agents | | Phase 4, Phase 3 | 2736 | | | | 42 | | Chelating Agents | | Phase 4 | 1423 | | | | 43 | | Duloxetine Hydrochloride | | Phase 4 | 270 | | | | 44 | | Antibiotics, Antitubercular | | Phase 4, Phase 3, Phase 2 | 7180 | | | | 45 | | Psychotropic Drugs | | Phase 4, Phase 3 | 6430 | | | | 46 | | Anti-Bacterial Agents | | Phase 4, Phase 3, Phase 2 | 11226 | | | | 47 | | Dihydroartemisinin | | Phase 4 | 95 | 71939-50-9 | 6918483 | (3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10-ol 1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol(Dihydroartemisinin) 71939-50-9 81496-81-3 AC-2067 AC1L32PY AC1L9UV6 Ambotz71939-50-9 Artenimol Artenimol (INN) CHEBI:207229 CHEMBL25164 CID107770 | CID456410 CID6918483 Cotecxin D07362 D3793 Dihydroartemisinin Dihydroartemisinine Dihydroqinghaosu Dihydroquinghaosu Dihydroquinghoasu GNF-PF-5634 JAV-110 LS-64240 VM3352 [3R-(3.alpha.,5a.beta.,6.beta.,8a.beta.,9.alpha.,10.alpha.,12.beta.,12aR*)]-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4.3-j]-1,2-benzodioxepin |
| | 48 | | Serotonin and Noradrenaline Reuptake Inhibitors | | Phase 4 | 457 | | | | 49 | | Ergocalciferols | | Phase 4, Phase 3 | 1281 | | | | 50 | | Hormones, Hormone Substitutes, and Hormone Antagonists | | Phase 4, Phase 3, Phase 1, Phase 2 | 13168 | | |
Interventional clinical trials: (show top 50)
(show all 82)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells（Umbilical Cord Derived） | Unknown status | NCT02218437 | Phase 4 | | 2 | Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects | Completed | NCT00634569 | Phase 4 | | 3 | A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency | Completed | NCT01289847 | Phase 4 | | 4 | Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients | Completed | NCT00121810 | Phase 4 | | 5 | Effects of Glucosamine and Chondroitin Supplementation in Women With Knee Osteoarthritis Participating in an Exercise and Weight Loss Program | Completed | NCT01271218 | Phase 4 | | 6 | Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD) | Completed | NCT01148511 | Phase 4 | | 7 | Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin | Completed | NCT01422382 | Phase 4 | | 8 | The Optimal Dose of Dexmedetomidine Sedation for Postpartum Parturients and Nonpregnant Women | Completed | NCT02111421 | Phase 4 | | 9 | ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria | Completed | NCT01375322 | Phase 4 | | 10 | Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) | Completed | NCT00907478 | Phase 4 | | 11 | The Influence of Age on Dexmedetomidine Pharmacodynamic | Completed | NCT02099253 | Phase 4 | | 12 | Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD) | Completed | NCT01135615 | Phase 4 | | 13 | Duloxetine Treatment in Elderly With Dysthymia | Completed | NCT01852383 | Phase 4 | | 14 | Impact of Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lampung Province, Sumatra | Completed | NCT01389557 | Phase 4 | | 15 | Paricalcitol Effect on Anemia in CKD | Completed | NCT01768351 | Phase 4 | | 16 | Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202) | Completed | NCT00993187 | Phase 4 | | 17 | Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Cases | Completed | NCT01392014 | Phase 4 | | 18 | On-pump Beating Coronary Artery Bypass Grafting by Ventricular Assist | Recruiting | NCT02731794 | Phase 4 | | 19 | The ED50 of DEX for Providing Sedation in Different Female Age Group | Not yet recruiting | NCT02773017 | Phase 4 | | 20 | Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. | Completed | NCT00278954 | Phase 3 | | 21 | An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy | Completed | NCT00883753 | Phase 3 | | 22 | Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients | Completed | NCT00220766 | Phase 3 | | 23 | Topical Green Tea Ointment in Treatment of Superficial Skin Cancer | Completed | NCT02029352 | Phase 2, Phase 3 | | 24 | Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO) | Completed | NCT00803634 | Phase 3 | | 25 | Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD) | Completed | NCT01020487 | Phase 3 | | 26 | Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection | Completed | NCT01069900 | Phase 3 | | 27 | A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis. | Completed | NCT00377637 | Phase 3 | | 28 | Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD) | Terminated | NCT01987960 | Phase 3 | | 29 | Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS) | Completed | NCT00885833 | Phase 1, Phase 2 | | 30 | Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells | Completed | NCT00730314 | Phase 1, Phase 2 | | 31 | Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy | Completed | NCT02372708 | Phase 2 | | 32 | A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer | Completed | NCT00118755 | Phase 2 | | 33 | Effects of the Anti-inflammatory Flavonoid Luteolin on Behavior in Children With Autism Spectrum Disorders | Completed | NCT01847521 | Phase 2 | | 34 | Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim | Completed | NCT01143038 | Phase 2 | | 35 | A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment | Completed | NCT01468077 | Phase 2 | | 36 | Gene Therapy for Wiskott-Aldrich Syndrome (WAS) | Recruiting | NCT01347242 | Phase 1, Phase 2 | | 37 | Gene Therapy for WAS | Recruiting | NCT01347346 | Phase 1, Phase 2 | | 38 | Gene Therapy for WAS Follow-up | Recruiting | NCT02333760 | Phase 1, Phase 2 | | 39 | A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients | Recruiting | NCT03019809 | Phase 2 | | 40 | Immune Disorder HSCT Protocol | Recruiting | NCT01821781 | Phase 2 | | 41 | Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases | Recruiting | NCT01852370 | Phase 1, Phase 2 | | 42 | Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT | Recruiting | NCT01962415 | Phase 2 | | 43 | Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders | Recruiting | NCT00919503 | Phase 2 | | 44 | Low Dose Cytarabine and Lintuzumab-Ac225 in Older AML Patients | Recruiting | NCT02575963 | Phase 1, Phase 2 | | 45 | Gene Therapy for Wiskott-Aldrich Syndrome | Active, not recruiting | NCT01515462 | Phase 2 | | 46 | Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome | Active, not recruiting | NCT01410825 | Phase 1, Phase 2 | | 47 | Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients | Active, not recruiting | NCT00909363 | Phase 2 | | 48 | Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies | Active, not recruiting | NCT01529827 | Phase 2 | | 49 | Belatacept Post Depletional Repopulation to Facilitate Tolerance | Active, not recruiting | NCT00565773 | Phase 2 | | 50 | Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells | Terminated | NCT02512679 | Phase 2 |
Cell-based therapeutics:Data from LifeMap, the Embryonic Development and Stem Cells Database Stem-cell-based therapeutic approaches for Wiskott-Aldrich Syndrome: Embryonic/Adult Cultured Cells Related to Wiskott-Aldrich Syndrome:
|
